FDA supports new medication for therapy of adults with chronic kidney infection Kumar Jeetendra | May 1, 2021 Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood …
Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes Kumar Jeetendra | May 5, 2021 Göteberg, Sweden – May 05, 2021 – Life Science Newswire – Takara Bio Europe AB (TBEAB) and PanCryos are pleased to announce that they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucose-responsive beta cells and is …
Researchers develop experimental direct-acting antiviral treatment to treat COVID-19 Kumar Jeetendra | May 18, 2021 An international team of scientists from the Menzies Health Institute Queensland (MHIQ) at Griffith University and from City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases in the U.S., have developed an experimental direct-acting antiviral therapy to treat COVID-19. Conventional antivirals reduce symptoms and help people recover earlier. Examples …
Growing genomic research into different ancestries yields more and better outcomes Kumar Jeetendra | June 1, 2021 Currently published in Nature Genetics, their findings demonstrate that expanding research into different ancestries yields more and better results, in addition to ultimately benefitting global patient care. Up to now nearly 87 percent of genomic research of the type was conducted in Europeans. The global study team examined data across a wide assortment of cohorts, …
Researchers develop AI-based model to analyze cardiovascular illnesses and diabetes Kumar Jeetendra | August 14, 2021 Scientists from South Ural State University (SUSU), along with colleagues from France, Spain, and Egypt, have created a model that can be used to diagnose cardiovascular diseases and diabetes more effectively using artificial intelligence and Internet of Things technology. The Russian Ministry of Science and Higher Education supported this work. In an article published in …
Why You Should Care About Insulin and Selenium Kumar Jeetendra | February 18, 2025 Health might seem to be just about diet; however, a large part depends on complex biochemical reactions that take place within the body. The processes of metabolism, immunity, and cellular activities are regulated with the help of a very diverse set of compounds. Insulin and selenite are just two of many, but their importance exceeds …
Targeted Therapies & Drug Design: Dr. Hemant R. Jadhav’s Insights Kumar Jeetendra | June 14, 2025 Dr. Hemant R. Jadhav, a BITS Pilani professor, spends his days sketching tiny drug-like shapes on a computer screen and nights watching them grow into real compounds. His work targets cancer, HIV, Alzheimer’s, and diabetes—blending molecular design with hands-on testing to yield future-ready therapies. At the core of his research are histone demethylases—epigenetic gatekeepers that …
